Atlas Trials

A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal Impairment

Clinical trial NCT07006688 · RECRUITING

Trial details

NCT number
NCT07006688
Sponsor
Servier Bio-Innovation LLC
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
IDH1-Mutated Malignancies
Start date
2026-01-14
Primary completion
2028-07-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.